Sequencing Immunotherapies and Targeted Therapies When Treating Patients with Melanoma

Summary: Melanoma is the most aggressive form of skin cancer and its incidence continues to increase dramatically. It is likely that more than 76,000 new cases will be diagnosed in the US in 2014. New therapeutic approaches are being aggressively sought that will positively impact patient quality of life and survival. Join us as Dr. John Kirkwood addresses how to sequence immunotherapies and targeted therapies to treat patients with melanoma. 0.25 CME Credits